H.R. 1539 · 119th Congress

Medical Device Electronic Labeling Act

Introduced on Feb 24, 2025 by Jay Obernolte (R-CA-23). 7 cosponsors, 4 of them from another party. Latest action (Feb 24, 2025): Referred to the House Committee on Energy and Commerce.

Stage
Introduced
Introduced
Feb 24, 2025
Cosponsors
7
4 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To amend the Federal Food, Drug, and Cosmetic Act to expand the types of devices for which required labeling may be made available solely by electronic means, and for other purposes.

Subjects

  • Computers and information technology
  • Consumer affairs
  • Drug safety, medical device, and laboratory regulation

Summary

By the Congressional Research Service (Introduced in House, Feb 24, 2025). Public domain.

Medical Device Electronic Labeling Act

This bill expands the permitted use of electronic labeling of medical devices to allow directions for use and warning labels for all medical devices to be provided electronically, rather than physically (i.e., affixed to or accompanying the device or its container).

(Under current law, direction and warning labels may be provided electronically only for (1) prescription devices intended for use in health care facilities or by health care professionals, and (2) in vitro diagnostic devices intended for use in blood establishments or by health care professionals.)

Under the bill, direction and warning labels may be provided solely electronically for all medical devices so long as (1) the electronic label is readily accessible to the device’s intended users, (2) intended users may request a paper label at no additional cost, and (3) the label affixed to the device or its packaging contains all information required under current laws and regulations.

The Food and Drug Administration may issue regulations establishing additional requirements or exceptions to these provisions.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Jay ObernolteR-CA-23Sponsor

Democrats · 4

Republicans · 3

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Feb 24, 2025Introduced in House
  2. Feb 24, 2025Introduced in House
  3. Feb 24, 2025 · HouseReferred to the House Committee on Energy and Commerce.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. DEXCOM, INC.6 reports
    $2.1M reported (all issues)
  2. JOHNSON & JOHNSON SERVICES, INC.6 reports
    $13.3M reported (all issues)
  3. MEDTRONIC INC.6 reports
    $6.8M reported (all issues)Federal contractor: MEDTRONIC USA INC$10M in contracts, FY2026AI match · 99%
  4. ADVANCED MEDICAL TECHNOLOGY ASSN4 reports
    $3.9M reported (all issues)
  5. COOK GROUP INC4 reports
    $640K reported (all issues)
  6. MEDICAL DEVICE MANUFACTURERS ASSOCIATION3 reports
  7. Philips Holding USA, Inc.2 reports
    $1.4M reported (all issues)
  8. American Medical Association1 report
    $8M reported (all issues)Federal contractor: AMERICAN MEDICAL ASSOCIATION$371K in contracts, FY2026AI match · 99%
  9. Breakthrough T1D (formerly known as JDRF Intl.)1 report
    $190K reported (all issues)
  10. ZIMMER BIOMET, INC.1 report
    $190K reported (all issues)Federal contractor: ZIMMER BIOMET SPINE, INC.$642.7K in contracts, FY2026AI match · 99%

Reports filed in 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 8, 2026 · loaded Oct 8, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 7, 2026 · loaded Oct 7, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.